Mediators of Inflammation / 2013 / Article / Tab 1

Research Article

Role of Cox-2 in Vascular Inflammation: An Experimental Model of Metabolic Syndrome

Table 1

The above values correspond to metabolic and cardiovascular variables.

VariablesWFFRSHRFFHRFFHR + L

SBP (mmHg)118 ± 0.8140 ± 1.8*172 ± 2.0*182 ± 1.1*#165 ± 0.9*
HOMA ( U/mL insulin × mmol/L glucose)/22.54.22 ± 1.111.9 ± 1.3*8.1 ± 2.2*15.1 ± 2.5*13.2 ± 2.1*
Fast glucemia (mmol/L)4.0 ± 1.16.8 ± 1.3*5.2 ± 1.3*6.92 ± 2.1*6.5 ± 2.1*
Tryglycerides (mg/dL)72.5 ± 1.9109 ± 1.8*115 ± 2.4*149 ± 2.2*#140.9 ± 2.4*
Relative heart weight (mg/100 g corporal weight)229 ± 2.5302 ± 2.1*425 ± 4.4*475 ± 2.6*#389 ± 2*
Vascular NAD(P)H-oxidase activity (cpm/mg)14.5 ± 3.368 ± 1.4*149 ± 2.6*366 ± 12*#197 ± 2.3*#†
TBARS (mmol/L)39 ± 3.2118 ± 5.4*110 ± 3.9*171 ± 2.6*#101 ± 2.7*#†
Arterial eNOS activity (dpm·mg P/min)82.0 ± 262 ± 1.5*81.9 ± 2.650.6 ± 1.9*#71.4 ± 1.1*#†
L/M relationship13.1 ± 1.49.5 ± 1.2*8.9 ± 2.1*7.4 ± 1.2*#11.5 ± 1.1*#†
PCRus1.18 ± 0.13.2 ± 0.3*4.5 ± 0.1*6.7 ± 0.2*#1.1 ± 0.2*#

* versus WKY; versus SHR; # versus FFR. versus FFHR.